Fundraising Fox
🦊/Companies
Sign in

Teknova

Founded 1996 · 192 employees on LinkedIn · 1 known investors

Find your way into Teknova

Teknova develops reagents and custom buffer solutions for AAV (adeno-associated virus) downstream processing in gene therapy workflows. The company leverages 30 years of manufacturing expertise to address bottlenecks in AAV production for researchers and biotech organizations.

Advanced ManufacturingBiotechDeep Tech

Investors · 1

Telegraph Hill PartnersSan Francisco · $2M – $8M

In the news

Alpha Teknova Raises Outlook After Record Q2 Revenue at Sidoti Conferencefinance.yahoo.com · Aug 2026BTIG upgrades Alpha Teknova stock rating on improving fundamentals By Investing.cominvesting.com · Aug 2026Alpha Teknova (Nasdaq: TKNO) raises 2026 guidance after Q2 growthstocktitan.net · Aug 2026Earnings call transcript: Teknova posts record Q2 2026 revenue and raises outlook By Investing.cominvesting.com · Aug 2026Teknova outlines 20%-25% long-term revenue growth target while investing $2M annually in commercial capabilities (NASDAQ:TKNO) | Seeking Alphaseekingalpha.com · Feb 2026

Frequently asked questions

What does Teknova do?
Teknova develops reagents and custom buffer solutions for AAV (adeno-associated virus) downstream processing in gene therapy workflows. The company leverages 30 years of manufacturing expertise to address bottlenecks in AAV production for researchers and biotech organizations.
Who are Teknova's investors?
Teknova's investors include Telegraph Hill Partners.